Anzeige
Mehr »
Login
Mittwoch, 23.10.2024 Börsentäglich über 12.000 News von 675 internationalen Medien
Goldpreise steigen über $2.700 - Hier ist der Bergbaukonzern, der jetzt davon profitieren könnte
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche
PR Newswire
681 Leser
Artikel bewerten:
(2)

Neat Raises Fresh Funding as COVID-19 Drives Demand for its FinTech Platform to help SMEs Grow Internationally

HONG KONG, Aug. 19, 2020 /PRNewswire/ -- Neat, a Hong Kong-based FinTech company offering online company incorporation and multi-currency wallets to cross-border SMEs, today announced raising a US$4M extension to their US$11M Series A round closed in April 2020. Existing investors MassMutual Ventures, Pacific Century Group, Linear Capital and Robby Hilkowitz as well as new investor Vectr Fintech participated in the Series A Extension.

Neat Product Image

Neat Product Image

David Rosa, CEO & Co-Founder

David Rosa, CEO & Co-Founder; Igor Wos, CTO & Co-Founder

Igor Wos, CTO & Co-Founder

Neat Logo

Neat's vision is to enable the entrepreneur economy and support SMEs trading globally. While global travel has come to a standstill, cross-border trade has not. SMEs trading internationally are increasingly looking for online alternatives to facilitate their international business needs.

Neat's online company incorporation package and fully-digital multi-currency wallet, perfectly fit the needs of international entrepreneurs today.

While COVID-19 has caused an economic slowdown, new company incorporations are still on the rise with more than 175,000 new companies incorporated in the UK in Q2 of 2020 compared to 170,000 the same period last year; in Hong Kong, over 27,000 companies were incorporated in Q2 of 2020.[1] These are companies that may previously have turned to high street banking providers, but are now looking at digital alternatives to get their businesses up-and-running.

"Some of the world's most successful companies were born during or just after the financial crisis of 2008, think of WhatsApp and Uber. The majority of businesses founded during COVID-19 will have a digital-first mindset, which means they will have an opportunity to start trading globally from day one. We're excited to be supporting this new wave of international entrepreneurs," said David Rosa, CEO of Neat.

With its offering of online company incorporation, multi-currency wallet, corporate expense cards and international remittances, Neat is primarily focussed on SMEs trading between Europe and Asia. Over the next few years, Neat aims to make international trade frictionless by not only offering a way for customers to move money, but also making use of a vast ecosystem of tools that automate their business processes (payroll, accounting, logistics, etc.), to ultimately enable anyone to run an international business with ease.

"Neat has shown great resilience and momentum throughout the current pandemic. The demand for online alternatives to banks has gone up, and the team at Neat has proven their ability to capture this opportunity while maintaining strong unit economics. The new capital injection will allow Neat to double down on their customer acquisition efforts to serve more SMEs looking for a better way to manage their business finances." said Mark Munoz, Managing Partner at Vectr Fintech Partners

About Neat

Neat's mission is to enable the entrepreneur economy - starting with fully digital multi-currency accounts built for today's international entrepreneur. The Neat Account gives you the ability to send and receive money globally at more competitive exchange rates than you would get from a bank; access Neat corporate expense cards for online and offline spending, as well as ATM withdrawals; it also includes intuitive expense tracking and security features. Learn more at www.neatcommerce.com.

Note for Editor

Neat is not a bank and should not be referred to as a bank, business account or bank account. You may refer to Neat's services as "alternative to a bank", "banking alternative", "multi-currency wallet".

Neat's Hong Kong arm, Neat Limited, is licensed as a Money Service Operator (No. 19-06-02796), Trust or Corporate Service Provider (TC006452) and Money Lender (No. 0464/2020). Our UK arm, Neat Global Limited, is a registered agent of PayrNet Limited which is an Electronic Money Institution authorised by the Financial Conduct Authority under the Electronic Money Regulations 2011 (900594) for the issuing of electronic money.

Neat partners with various regulated financial institutions and banks to provide payment services.

More information: https://www.neatcommerce.com/business/security

[1] https://www.gov.uk/government/statistics/incorporated-companies-in-the-uk-april-to-june-2020;
https://www.cr.gov.hk/en/publication/fact-stat/statistics/local-companies-incorporated/since-2014.htm

Photo - https://mma.prnewswire.com/media/1228608/Neat_Dashboard_and_app.jpg
Photo - https://mma.prnewswire.com/media/1228609/Neat_Business_Dashboard.jpg
Photo - https://mma.prnewswire.com/media/1228610/David_Rosa_3.jpg
Photo - https://mma.prnewswire.com/media/1228612/Neat_Co_Founders.jpg
Photo - https://mma.prnewswire.com/media/1228613/Igor_Wos_2.jpg
Logo - https://mma.prnewswire.com/media/1228614/Neat_Sq_Logo.jpg

© 2020 PR Newswire
Tenbagger-Chance mit der nächsten BioNTech

Erinnern Sie sich, als Moderna und BioNTech von unbekannten Unternehmen zu globalen Marktführern wurden und frühzeitige Investoren reich belohnt haben?

Die Branche steht vor einem erneuten Innovationsschub – von bahnbrechenden Medikamenten bis hin zu revolutionären Therapien.

Warum sollten Sie dabei sein?

Sie sollten jetzt in Biotech-Aktien einsteigen, weil wir am Beginn einer neuen Ära der medizinischen Innovation stehen könnten! Gen- und Zelltherapien, personalisierte Medizin und bahnbrechende Technologien könnten das Gesundheitswesen revolutionieren – und die Aktienkurse in die Höhe schießen lassen.

Die nächste Erfolgsgeschichte im Biotechbereich warten nur darauf, entdeckt zu werden. Wer jetzt investiert, hat die Chance, von gigantischen Durchbrüchen und enormen Renditen zu profitieren. Warten Sie nicht, bis es zu spät ist - der nächste Biotech-Superstar könnte morgen schon durchstarten!

Verpassen Sie nicht diese Chance!

Fordern Sie sofort unseren brandneuen Biotech-Spezialreport an und erfahren Sie, welche 3 Biotech-Aktien das riesige Potenzial haben, Ihren finanziellen Erfolg zu sichern. Dieser Report ist komplett kostenlos und zeigt Ihnen zukunftsträchtige Investments im Biotech-Sektor.

Handeln Sie jetzt und sichern Sie sich Ihren kostenfreien Report!

Werbehinweise: Die Billigung des Basisprospekts durch die BaFin ist nicht als ihre Befürwortung der angebotenen Wertpapiere zu verstehen. Wir empfehlen Interessenten und potenziellen Anlegern den Basisprospekt und die Endgültigen Bedingungen zu lesen, bevor sie eine Anlageentscheidung treffen, um sich möglichst umfassend zu informieren, insbesondere über die potenziellen Risiken und Chancen des Wertpapiers. Sie sind im Begriff, ein Produkt zu erwerben, das nicht einfach ist und schwer zu verstehen sein kann.